甲状腺髓样癌基因表达分类器的分析性能
本研究评估一种用于甲状腺髓样癌(MTC)的RNA分类器的分析性能。采用27例经组织病理学确诊的MTC组织标本,回顾性测得分类器灵敏度为96.3%(置信区间81.0-99.9%)。分类器在RNA输入量5-25 ng、基因组DNA污染30%(按质量计)及血液干扰下结果均100%准确,两实验室间20例组织结果100%一致。
要点
- 27例确诊MTC组织标本回顾性测得分类器灵敏度96.3%(CI 81.0-99.9%)。
- MTC样本稀释至20%比例时仍可一致检出,体外确认20%分析灵敏度。
- RNA输入5-25 ng、基因组DNA污染30%(按质量计)及血液干扰下分类器结果100%准确。
核心结论
- MTC分类器作为细胞学不确定甲状腺结节常规分子检测的一部分,表现出稳健的分析灵敏度、特异性、准确性和可重复性。
研究设计与样本
- 研究采用商业来源的新鲜冷冻组织标本,经组织病理学复核确认MTC诊断。
- 获取去标识患者细针穿刺活检(FNAB)标本及正常供者全血,提取总RNA、扩增并杂交至定制微阵列进行基因表达分析。
- 基因表达数据经归一化后通过机器学习算法分类,阳性对照材料由MTC组织制备并在多实验和多实验室中测试。
主要发现
- 27例确诊MTC组织标本回顾性测得MTC分类器灵敏度为96.3%(置信区间81.0-99.9%)。
- 1例坏死组织出现假阴性结果,提示样本坏死与分类器灵敏度降低有关。
- MTC样本与正常或良性组织稀释建模显示,样本比例低至20%时仍可一致检出MTC,体外确认20%分析灵敏度。
- 分类器在RNA输入量5-25 ng、基因组DNA污染30%(按质量计)及干扰物质(血液)存在下,所有测试条件下分类器结果100%准确。
- 单个FNAB样本的最大批间评分差约为1单位,而38例MTC与非MTC FNAB之间的平均评分差约为32单位。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to demonstrate the analytical validity of an RNA classifier for medullary thyroid carcinoma (MTC). METHODS: Fresh-frozen tissue specimens were obtained from commercial sources, and MTC diagnoses were confirmed by histopathology review. De-identified patient fine-needle aspiration biopsies (FNABs) and whole blood from normal donors were obtained. Total RNA was extracted, amplified, and hybridized to custom microarrays for gene expression analysis. Gene expression data were normalized and classified via a machine learning algorithm. Positive control materials were produced from MTC tissues and tested across multiple experiments and laboratories. Twenty-seven MTC tissue specimens were used to evaluate the sensitivity of the MTC classifier. Gene expression data from tissues and FNABs were used to model classifier response to mixtures of MTC samples with normal thyroid tissue, a benign thyroid nodule, a Hürthle cell adenoma, and whole blood. Select mixture conditions were confirmed in vitro. Assay tolerance to RNA input variation (5-25 ng) and genomic DNA contamination (30% by mass) was evaluated. The intra- and inter-run reproducibility and inter-laboratory accuracy of MTC classifier results were characterized. RESULTS: The MTC classifier sensitivity of 96.3% [confidence interval 81.0-99.9%] was determined retrospectively using 27 MTC confirmed tissue specimens. One false-negative result in a necrotic tissue implicated sample necrosis in reduced classifier sensitivity. Dilution modeling of MTC samples with normal or benign tissues showed consistent detection of MTC down to 20% sample proportions, with in vitro confirmation of 20% analytical sensitivity. Classifier tolerance to RNA input variation (5-25 ng), genomic DNA contamination (30% by mass), and an interfering substance (blood) was demonstrated with 100% accurate classifier results under all tested conditions. The maximum observed run-to-run score difference for a single FNAB sample was ∼1 unit compared with the average score difference between 38 MTC and non-MTC FNABs of ∼32 units. MTC classifier results for 20 tissues processed from total RNA in two different laboratories showed 100% concordance. CONCLUSIONS: The MTC classifier, offered as part of the routine molecular testing of cytology-indeterminate thyroid nodules, demonstrates robust analytical sensitivity, specificity, accuracy, and reproducibility.
引用
- Pankratz DG, Hu Z, Kim SY, et al. Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma. Thyroid. 2016. PMID: 27605259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。